Nova Steroid Pharma Co.,Ltd

What is this CAS: 1196133-39-7 number?

May 31, 2024

    CAS: 1196133-39-7 refers to the unique Chemical Abstracts Service (CAS) registry number assigned to the selective androgen receptor modulator (SARM) known as LGD3303. This registry number is a globally recognized identifier used to provide a unique, unmistakable identifier for chemical substances, enabling more precise communication and data retrieval in scientific and regulatory contexts. By using this CAS number, researchers and professionals can accurately identify and obtain specific information about LGD3303 without confusion arising from different naming conventions or synonyms that might exist in various regions or publications.

    LGD3303, linked with the CAS number 1196133-39-7, is a compound developed to enhance muscle growth and improve bone density by selectively targeting androgen receptors in muscle and bone tissues. Unlike traditional anabolic steroids, which can affect multiple tissues and lead to a range of unwanted side effects, SARMs like LGD3303 aim to deliver anabolic benefits specifically to desired tissues. This selective activity holds potential for therapeutic applications in treating conditions such as muscle wasting diseases and osteoporosis, as well as for performance enhancement in sports and bodybuilding.

    Despite its promising properties, LGD3303's safety and efficacy are not fully established due to the limited scope of current research. Most of the available data derives from animal studies and anecdotal reports, with only a few human trials conducted so far. Consequently, the long-term effects and potential health risks of LGD3303 remain uncertain. The legal status of LGD3303 varies globally, with some jurisdictions permitting its use strictly for research purposes while others ban it altogether. Given these factors, individuals interested in using LGD3303 should proceed with caution, thoroughly reviewing the available scientific literature and legal guidelines, and ideally consulting healthcare professionals before considering its use. As research continues, more comprehensive data will hopefully clarify the benefits and risks associated with this compound.

goTop